IRulya Therapeutics, Inc. (IRLA)
31.08
+1.77
(+6.04%)
USD |
NASDAQ |
Nov 06, 15:22
IRulya Therapeutics Net Income (TTM) : -92.48M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -92.48M |
| March 31, 2026 | -33.04M |
| December 31, 2025 | -83.98M |
| September 30, 2025 | -56.98M |
| June 30, 2025 | -49.03M |
| March 31, 2025 | -60.71M |
| December 31, 2024 | -56.83M |
| September 30, 2024 | -53.26M |
| June 30, 2024 | -53.12M |
| March 31, 2024 | -30.28M |
| December 31, 2023 | -31.38M |
| September 30, 2023 | -28.02M |
| June 30, 2023 | -30.60M |
| March 31, 2023 | -42.27M |
| December 31, 2022 | -51.66M |
| Date | Value |
|---|---|
| September 30, 2022 | -69.52M |
| June 30, 2022 | -83.31M |
| March 31, 2022 | -88.50M |
| December 31, 2021 | -89.94M |
| September 30, 2021 | -87.10M |
| June 30, 2021 | -86.90M |
| March 31, 2021 | -82.76M |
| December 31, 2020 | -76.85M |
| September 30, 2020 | -68.67M |
| June 30, 2020 | -57.02M |
| March 31, 2020 | -48.48M |
| December 31, 2019 | -36.98M |
| September 30, 2019 | -27.71M |
| June 30, 2019 | -21.23M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Korsana Biosciences, Inc. | -6.707M |
| PepGen Inc. | -71.94M |
| Q32 Bio, Inc. | 32.25M |
| Bridgebio Oncology Therapeutics, Inc. | -182.11M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |